Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain

Journal of Chemical Neuroanatomy

Volumn 43, Issue 1, 2012, Pages 48-51

  Dhull, Dinesh K ^a   Bhateja, Deepak ^a   Dhull, Rakesh K ^b   Padi, Satyanarayana S V ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cyclooxygenase; Hippocampus CA1; ICV STZ; Nissl stain

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; ETORICOXIB; PHENACETIN; SALICYLIC ACID; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; MALE; MICROSCOPY; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CELL SURVIVAL; CYCLOOXYGENASE INHIBITORS; MALE; NEURONS; PHENACETIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIDINES; RATS; RATS, WISTAR; SALICYLIC ACIDS; STREPTOZOCIN; SULFONES;

EID: 84856519296     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.10.001     Document Type: Article

References (26)

1. Budson A.E. Understanding memory dysfunction. Neurologist 2009, 15:71-79.
2. Candelario-Jalil E., González-Falcón A., García-Cabrera M., Alvarez D., Al Dalain S., Martínez G., León O.S., Springer J.E. Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J. Neurochem. 2003, 86:545-555.
3. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13926-13931.
4. Dhull D.K., Jindal A., Dhull R.K., Aggarwal S., Bhateja D., Padi S.S.V. Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer's disease in rats. J. Mol. Neurosci. 2011, 10.1007/s12031-011-9583-6.
5. Eizirik D.L., Germano C.M., Migliorini R.H. Dietetic supplementation with branched chain amino acids attenuates the severity of streptozotocin-induced diabetes in rats. Acta. Diabetol. Lat. 1988, 25(2):117-126.
6. Gierse J.K., Zhang Y., Hood W.F., Walker M.C., Trigg J.S., Maziasz T.J., Koboldt C.M., Muhammad J.L., Zweifel B.S., Masferrer J.L., Isakson P.C., Seibert K. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. J. Pharmacol. Exp. Ther. 2005, 312(3):1206-1212.
7. Hemler M., Lands W.E.M., Smith W.L. Purification of the cyclooxygenase that forms prostaglandins: demonstration of two forms of iron in the holoenzyme. J. Biol. Chem. 1976, 251:5575-5579.
8. Ishida T., Sato T., Irifune M., Tanaka K.I., Nakamura N., Nishikawa T. Effect of acetaminophen, a cyclooxygenase inhibitor, on Morris water maze task performance in mice. J. Psychopharmacol. 2007, 21:757-767.
9. Ishrat T., Parveen K., Khan M.M., Khuwaja G., Khan M.B., Yousuf S., Ahmad A., Shrivastav P., Islam F. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res. 2009, 1281:7-127.
10. Klivenyi P., Kiaei M., Gardian G., Calingasan N.Y., Beal M.F. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2004, 88:576-582.
11. Lazarov O., Marr R.A. Neurogenesis and Alzheimer's disease: at the crossroads. Exp. Neurol. 2010, 223:267-281.
12. Liu X.J., Lee T.L., Wong P.T.H. Cyclooxygenase-1 inhibition shortens the duration of diazepam-induced loss of righting reflex in mice. Anesth. Analg. 2006, 102:135-140.
13. Muller D., Nitsch R.M., Wurtman R.J., Hoyer S. Streptozotocin increases free fatty acids and decreases phospholipids in rat brain. J. Neural Transm. 1998, 105:1271-1281.
14. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 1998, 23:81-88.
15. Salkovic-Petrisic M., Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer like pathology: an experimental approach. J. Neural Transm. 2007, 72:217-233.
16. Saxena G., Bharti S., Kamat P.K., Sharma S., Nath C. Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pharmacol. Biochem. Behav. 2010, 94(3):397-403.
17. Shoham S., Bejar C., Kovalev E., Schorer-Apelbaum D., Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 2007, 52(3):836-843.
18. Shoham S., Bejar C., Kovalev E., Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp. Neurol. 2003, 184(2):1043-1052.
19. Song M.S., Rauw G., Baker G.B., Kar S. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur. J. Neurosci. 2008, 28(10):1989-2002.
20. Tahirovic I., Sofic E., Sapcanin A., Gavrankapetanovic I., Bach-Rojecky L., Salkovic-Petrisic M., Lackovic Z., Hoyer S., Riederer P. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. Neurochem. Res. 2007, 32(10):1709-1717.
21. Wahner A.D., Bronstein J.M., Bordelon Y.M., Ritz B. Nonsteroidal anti inflammatory drugs may protect against Parkinson disease. Neurology 2007, 69(19):1836-1842.
22. Wang X., Su B., Zheng L., Perry G., Smith M.A., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Neurochem. 2009, 109:153-159.
23. Willoughby D.A., Moore A.R., Colville-Nash P.R. COX-1, COX-2, and COX 3 and the future treatment of chronic inflammatory disease. Lancet 2000, 355(9204):646-648.
24. Xie W., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2692-2696.
25. Zhou Y., Qu Z.Q., Zeng Y.S., Lin Y.K., Li Y., Chung P., Wong R., Hägg U. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp. Toxicol. Pathol. 2011, 10.1016/j.etp.2010.12.011.
26. Zibell G., Unkrüer B., Pekcec A., Hartz A.M., Bauer B., Miller D.S., Potschka H. Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology 2009, 56(5):849-855.